Oxford Biolabs Limited - Filleted accounts

Registered number

07028185

Oxford Biolabs Limited

Filleted Accounts

31 January 2025

Oxford Biolabs Limited
Registered number:		07028185
Balance Sheet
as at 31 January 2025

Notes			2025			2024
£				£
Fixed assets
Intangible assets	3		789			2,721
Tangible assets	4		4,199			7,394
Investments	5		-			754
			4,988			10,869

Current assets
Stocks		152,936			200,122
Debtors	6	145,382			151,115
Investments held as current assets	7	811,835			177,736
Cash at bank and in hand		447,833			769,095
		1,557,986			1,298,068

Creditors: amounts falling due within one year	8	(178,945)			(159,630)

Net current assets			1,379,041			1,138,438

Net assets			1,384,029			1,149,307

Capital and reserves
Called up share capital			1,000			1,000
Profit and loss account			1,383,029			1,148,307

Shareholder's funds			1,384,029			1,149,307

The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The member has not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.




T Whitfield
Director
Approved by the board on 24 October 2025

Oxford Biolabs Limited
Notes to the Accounts
for the year ended 31 January 2025


1	Accounting policies

	Basis of preparation
	The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).

	Turnover
	Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.

	Tangible fixed assets
	Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:

	Plant and machinery	33% straight line
	Fixtures, fittings, tools and equipment	over 5 years

	Investments
	Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.

	Stocks
	Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first in first out method. The carrying amount of stock sold is recognised as an expense in the period in which the related revenue is recognised.

	Debtors
	Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.

	Creditors
	Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.

	Taxation
	A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.

	Foreign currency translation
	Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

2	Employees		2025		2024
Number				Number

	Average number of persons employed by the company		0		0


3	Intangible fixed assets				£
	Goodwill:

	Cost
	At 1 February 2024				15,622
	At 31 January 2025				15,622

	Amortisation
	At 1 February 2024				12,901
	Provided during the year				1,932
	At 31 January 2025				14,833

	Net book value
	At 31 January 2025				789
	At 31 January 2024				2,721

	Product development is being written off in equal annual instalments over its estimated economic life of 5 years.


4	Tangible fixed assets
					Plant and machinery etc
£
	Cost
	At 1 February 2024				31,173
	At 31 January 2025				31,173

	Depreciation
	At 1 February 2024				23,779
	Charge for the year				3,195
	At 31 January 2025				26,974

	Net book value
	At 31 January 2025				4,199
	At 31 January 2024				7,394


5	Investments
Investments in
subsidiary
undertakings
£
	Cost
	At 1 February 2024				754
	Disposals				(754)

	At 31 January 2025				-


6	Debtors		2025		2024
£				£

	Trade debtors		130,059		144,338
	Other debtors		15,323		6,777
			145,382		151,115


7	Investments held as current assets		2025		2024
£				£
	Fair value
	Unlisted investments		811,835		177,736

	Increase/(decrease) in fair value included in the profit and loss account for the financial year
	Unlisted investments		205,277		(7,564)



8	Creditors: amounts falling due within one year		2025		2024
£				£

	Trade creditors		162,500		82,276
	Taxation and social security costs		13,455		30,595
	Other creditors		2,990		46,759
			178,945		159,630


9	Other information

	Oxford Biolabs Limited is a private company limited by shares and incorporated in England. Its registered office is:
	Magdalen Centre, The Oxford Science Park
	Robert Robinson Avenue
	Oxford
	Oxfordshire
	OX4 4GA